Average Co-Inventor Count = 4.04
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aduro Biotech Holdings, Europe B.v. (12 from 12 patents)
2. Merck Sharp + Dohme B.v. (2 from 55 patents)
3. Bionovion Holding B.v. (2 from 2 patents)
4. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
5. Msd Oss B.v. (1 from 17 patents)
17 patents:
1. 12168693 - Combining CD27 agonists and immune checkpoint inhibition for immune stimulation
2. 12145992 - Method of treating IgA nephropathy by administering altered antibodies which bind human a proliferation-inducing ligand (APRIL) protein
3. 11959924 - Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a sample
4. 11117961 - Antibodies to human programmed death receptor PD-1
5. 11047864 - Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a human sample
6. 10961316 - Humanized antibodies which bind to human APRIL ('a proliferation-inducing ligand')
7. 10851164 - Anti-SIRPα antibodies
8. 10808030 - Anti-HCTLA-4 antibodies
9. 10556957 - Anti-CD27 antibodies
10. 10494436 - Anti-PD-1 antibodies
11. 10377830 - Method of treating IgA nephropathy by administering humanized APRIL-binding antibodies
12. 10107821 - Proliferation-inducing ligand (APRIL)-binding peptides
13. 9969808 - Altered APRIL binding antibodies
14. 9527916 - Agonistic antibody to CD27
15. 9000128 - Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof